Retroperitoneal Lymph Node Dissection in Colorectal Cancer with Lymph Node Metastasis: A Systematic Review

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Jan 21

PMID 36672404

Authors

Michael G Fadel

Mosab Ahmed

Gianluca Pellino

Shahnawaz Rasheed

Paris Tekkis

David Nicol

Christos Kontovounisios

Erik Mayer

Affiliations

Soon will be listed here.

Abstract

The benefits and prognosis of RPLND in CRC have not yet been fully established. This systematic review aimed to evaluate the outcomes for CRC patients with RPLNM undergoing RPLND. A literature search of MEDLINE, EMBASE, EMCare, and CINAHL identified studies from between January 1990 and June 2022 that reported data on clinical outcomes for patients who underwent RPLND for RPLNM in CRC. The following primary outcome measures were derived: postoperative morbidity, disease free-survival (DFS), overall survival (OS), and re-recurrence. Nineteen studies with a total of 541 patients were included. Three hundred and sixty-three patients (67.1%) had synchronous RPLNM and 178 patients (32.9%) had metachronous RPLNM. Perioperative chemotherapy was administered in 496 (91.7%) patients. The median DFS was 8.6-38.0 months and 5-year DFS was 24.4% (10.0-60.5%). The median OS was 25.0-83.0 months and 5-year OS was 47.0% (15.0-87.5%). RPLND is a feasible treatment option with limited morbidity and possible oncological benefit for both synchronous and metachronous RPLNM in CRC. Further prospective clinical trials are required to establish a better evidence base for RPLND in the context of RPLNM in CRC and to understand the timing of RPLND in a multimodality pathway in order to optimise treatment outcomes for this group of patients.

Citing Articles

Focusing on chylous ascites: a noteworthy complication after laparoscopic/robotic para-aortic lymphadenectomy in left-sided colorectal cancer in a high-volume single center.

Sun Y, Tang Z, Wang X, Xu Z, Huang Y, Chi P Tech Coloproctol. 2025; 29(1):78.

PMID: 40055187 PMC: 11889067. DOI: 10.1007/s10151-025-03120-8.

Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.

Grange R, Rousset P, Williet N, Guesnon M, Milot L, Passot G Ann Surg Oncol. 2024; 31(4):2378-2390.

PMID: 38170409 DOI: 10.1245/s10434-023-14840-2.

References

Yamamoto S, Kanai T, Yo K, Hongo K, Takano K, Tsutsui M . Laparoscopic para-aortic lymphadenectomy for colorectal cancer with clinically suspected lymph node metastasis. Asian J Endosc Surg. 2018; 12(4):417-422. DOI: 10.1111/ases.12666. View

Nordlinger B, Sorbye H, Glimelius B, Poston G, Schlag P, Rougier P . Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008; 371(9617):1007-16. PMC: 2277487. DOI: 10.1016/S0140-6736(08)60455-9. View

Meijer R, de Valk K, Deken M, Boogerd L, Hoogstins C, Bhairosingh S . Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA. Eur J Surg Oncol. 2020; 47(3 Pt B):667-673. DOI: 10.1016/j.ejso.2020.10.034. View

Nakai N, Yamaguchi T, Kinugasa Y, Shiomi A, Kagawa H, Yamakawa Y . Diagnostic value of computed tomography (CT) and positron emission tomography (PET) for paraaortic lymph node metastasis from left-sided colon and rectal cancer. Asian J Surg. 2019; 43(6):676-682. DOI: 10.1016/j.asjsur.2019.09.001. View

Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T . Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000; 231(4):487-99. PMC: 1421023. DOI: 10.1097/00000658-200004000-00006. View

Ogura A, Akiyoshi T, Takatsu Y, Nagata J, Nagasaki T, Konishi T . The significance of extended lymphadenectomy for colorectal cancer with isolated synchronous extraregional lymph node metastasis. Asian J Surg. 2016; 40(4):254-261. DOI: 10.1016/j.asjsur.2015.10.003. View

Gagniere J, Dupre A, Chabaud S, Peyrat P, Meeus P, Rivoire M . Retroperitoneal nodal metastases from colorectal cancer: Curable metastases with radical retroperitoneal lymphadenectomy in selected patients. Eur J Surg Oncol. 2015; 41(6):731-7. DOI: 10.1016/j.ejso.2015.03.229. View

Mittakanti H, Porter J . Robot-assisted laparoscopic retroperitoneal lymph node dissection: a minimally invasive surgical approach for testicular cancer. Transl Androl Urol. 2020; 9(Suppl 1):S66-S73. PMC: 6995851. DOI: 10.21037/tau.2019.12.36. View

Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Ueno K, Tajima H . Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery?. Cancer. 1999; 85(3):583-90. DOI: 10.1002/(sici)1097-0142(19990201)85:3<583::aid-cncr8>3.0.co;2-j. View

10.

van der Vorst J, Schaafsma B, Hutteman M, Verbeek F, Liefers G, Hartgrink H . Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer. 2013; 119(18):3411-8. PMC: 3775857. DOI: 10.1002/cncr.28203. View

11.

Bae S, Baek S, Hur H, Baik S, Kim N, Min B . Intraoperative near infrared fluorescence imaging in robotic low anterior resection: three case reports. Yonsei Med J. 2013; 54(4):1066-9. PMC: 3663213. DOI: 10.3349/ymj.2013.54.4.1066. View

12.

Aoki T, Murakami M, Koizumi T, Matsuda K, Fujimori A, Kusano T . Determination of the surgical margin in laparoscopic liver resections using infrared indocyanine green fluorescence. Langenbecks Arch Surg. 2018; 403(5):671-680. DOI: 10.1007/s00423-018-1685-y. View

13.

Kim Y, Park I, Park J, Kim T, Ro J, Lim S . Management of isolated para-aortic lymph node recurrence after surgery for colorectal cancer. Ann Surg Treat Res. 2020; 98(3):130-138. PMC: 7052390. DOI: 10.4174/astr.2020.98.3.130. View

14.

Ho T, Mack L, Temple W . Operative salvage for retroperitoneal nodal recurrence in colorectal cancer: a systematic review. Ann Surg Oncol. 2010; 18(3):697-703. DOI: 10.1245/s10434-010-1322-7. View

15.

Ike H, Shimada H, Ohki S, Togo S, Yamaguchi S, Ichikawa Y . Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum. 2002; 45(4):468-73; discussion 473-5. DOI: 10.1007/s10350-004-6222-0. View

16.

Laukka M, Mannisto S, Beule A, Kouri M, Blomqvist C . Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: a prospective trial. Acta Oncol. 2020; 59(6):660-665. DOI: 10.1080/0284186X.2020.1725243. View

17.

Zizzo M, Dorma M, Zanelli M, Sanguedolce F, Bassi M, Palicelli A . Long-Term Outcomes of Surgical Resection of Pathologically Confirmed Isolated Para-Aortic Lymph Node Metastases in Colorectal Cancer: A Systematic Review. Cancers (Basel). 2022; 14(3). PMC: 8833834. DOI: 10.3390/cancers14030661. View

18.

Ichikawa Y, Takahashi H, Fujii M, Hata T, Ogino T, Miyoshi N . Radical lymphadenectomy of a para-aorta lymph node metastasis in colorectal cancer prolongs relapse-free survival. Int J Colorectal Dis. 2021; 36(7):1551-1560. DOI: 10.1007/s00384-021-03961-3. View

19.

Arimoto A, Uehara K, Kato T, Nakamura H, Kamiya T, Nagino M . Clinical Significance of Para-Aortic Lymph Node Dissection for Advanced or Metastatic Colorectal Cancer in the Current Era of Modern Chemotherapy. Dig Surg. 2015; 32(6):439-44. DOI: 10.1159/000439547. View

20.

Bae S, Hur H, Min B, Baik S, Lee K, Kim N . Which Patients with Isolated Para-aortic Lymph Node Metastasis Will Truly Benefit from Extended Lymph Node Dissection for Colon Cancer?. Cancer Res Treat. 2017; 50(3):712-719. PMC: 6056972. DOI: 10.4143/crt.2017.100. View